Epigenetics and Depression: An Update
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective Depression is associated with various environmental risk factors such as stress, childhood maltreatment experiences, and stressful life events. Current approaches to assess the pathophysiology of depression, such as epigenetics and gene-environment (GxE) interactions, have been widely leveraged to determine plausible markers, genes, and variants for the risk of developing depression. Methods We focus on the most recent developments for genomic research in epigenetics and GxE interactions. Results In this review, we first survey a variety of association studies regarding depression with consideration of GxE interactions. We then illustrate evidence of epigenetic mechanisms such as DNA methylation, microRNAs, and histone modifications to influence depression in terms of animal models and human studies. Finally, we highlight their limitations and future directions. Conclusion In light of emerging technologies in artificial intelligence and machine learning, future research in epigenetics and GxE interactions promises to achieve novel innovations that may lead to disease prevention and future potential therapeutic treatments for depression.
Abstract
Objective Depression is associated with various environmental risk factors such as stress, childhood maltreatment experiences, and stressful life events. Current approaches to assess the pathophysiology of depression, such as epigenetics and gene-environment (GxE) interactions, have been widely leveraged to determine plausible markers, genes, and variants for the risk of developing depression. Methods We focus on the most recent developments for genomic research in epigenetics and GxE interactions. Results In this review, we first survey a variety of association studies regarding depression with consideration of GxE interactions. We then illustrate evidence of epigenetic mechanisms such as DNA methylation, microRNAs, and histone modifications to influence depression in terms of animal models and human studies. Finally, we highlight their limitations and future directions. Conclusion In light of emerging technologies in artificial intelligence and machine learning, future research in epigenetics and GxE interactions promises to achieve novel innovations that may lead to disease prevention and future potential therapeutic treatments for depression.
참고문헌 (87)
- Lin E, "Understanding Depression", pp.41~50 (2018), Springer
- Peña CJ, "Progress in Molecular Biology and Translational Science", pp.41~66 (2018), Elsevier
- Howard DM, "Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways", Nat Commun, 9, pp.1470~ (2018)
- Hyde CL, "Identification of 15 genetic loci associated with risk of major depression in individuals of European descent", Nat Genet, 48, pp.1031~1036 (2016)
- Wray NR, "Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression", Nat Genet, 50, pp.668~681 (2018)
- Howard DM, "Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions", Nature Neurosci, 22, pp.343~352 (2019)
- Menke A, "Epigenetics, depression and antidepressant treatment", Curr Pharm Des, 18, pp.5879~5889 (2012)
- Nestler EJ, "Epigenetic mechanisms of depression", JAMA Psychiatry, 71, pp.454~456 (2014)
- Dalton VS, "Epigenetics and depression : return of the repressed", J Affect Disord, 155, pp.1~12 (2014)
- Shapero BG, "Stressful life events and depression symptoms : the effect of childhood emotional abuse on stress reactivity", J Clin Psychol, 70, pp.209~223 (2014)
- Sharma S, "Gene x environment determinants of stress-and anxiety-related disorders", Ann Rev Psychol, 67, pp.239~261 (2016)
- Caspi A, "Influence of life stress on depression : moderation by a polymorphism in the 5-HTT gene", Science, 301, pp.386~389 (2003)
- Gibb BE, "Serotonin transporter(5-HTTLPR)genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients", Suicide Life Threat Behav, 36, pp.687~693 (2006)
- Lin E, "Understanding Suicide", pp.85~95 (2016), Springer
- Roy A, "Interaction between childhood trauma and serotonin transporter gene variation in suicide", Neuropsychopharmacology, 32, pp.2046~2052 (2007)
- Cicchetti D, "Interaction of child maltreatment and 5-HTT polymorphisms : suicidal ideation among children from low-SES backgrounds", J Pediatr Psychol, 35, pp.536~546 (2009)
- Appel K, "Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population", Neuropsychopharmacology, 36, pp.1982~1991 (2011)
- Kohrt BA, "Cross-cultural gene−environment interactions in depression, post-traumatic stress disorder, and the cortisol awakening response : FKBP5 polymorphisms and childhood trauma in South Asia : GxE interactions in South Asia", Int Rev Psychiatry, 27, pp.180~196 (2015)
- Roy A, "Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide", Neuropsychopharmacology, 35, pp.1674~1683 (2010)
- Ben‐Efraim Y, "Gene–environment interactions between CRHR1 variants and physical assault in suicide attempts", Genes Brain Behav, 10, pp.663~672 (2011)
- Roy A, "Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior", J Psychiatr Res, 46, pp.72~79 (2012)
- Ben-Efraim Y, "Family-based study of HTR2A in suicide attempts : observed gene, gene×environment and parent-of-origin associations", Mol Psychiatry, 18, pp.758~766 (2013)
- Zimmermann P, "Interaction of FKBP5 gene variants and adverse life events in predicting depression onset : results from a 10-year prospective community study", Am J Psychiatry, 168, pp.1107~1116 (2011)
- Szczepankiewicz A, "FKBP5 polymorphism is associated with major depression but not with bipolar disorder", J Affect Disord, 164, pp.33~37 (2014)
- Lane HY, "Assessing gene-gene interactions in pharmacogenomics", Mol Diagn Ther, 16, pp.15~27 (2012)
- Lin E, "Pharmacogenomics with antidepressants in the STAR*D study", Pharmacogenomics, 9, pp.935~946 (2008)
- Culverhouse RC, "Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression", Mol Psychiatry, 23, pp.133~142 (2018)
- Heim C, "Current research trends in early life stress and depression : review of human studies on sensitive periods, gene–environment interactions, and epigenetics", Exp Neurol, 233, pp.102~111 (2012)
- Dunn EC, "Genome‐wide association study(GWAS)and genome‐wide by environment interaction study(GWEIS)of depressive symptoms in African American and Hispanic", Latina women, 2016, pp.33, 265~280
- Otowa T, "The first pilot genome-wide gene-environment study of depression in the Japanese population", PLoS one, 11, pp.e0160823~ (2016)
- Van der Auwera S, "Genome‐wide gene‐environment interaction in depression : a systematic evaluation of candidate genes : the childhood trauma workinggroup of PGC‐MDD", Am J Med Genet B Neuropsychiatr Genet, 177, pp.40~49 (2018)
- Cattaneo A, "FoxO1, A2M, and TGF-β1 : three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses", Mol Psychiatry, 23, pp.2192~2208 (2018)
- Peña CJ, "Epigenetic signaling in psychiatric disorders", J Mol Biol, 426, pp.3389~3412 (2014)
- Klose RJ, "Genomic DNA methylation : the mark and its mediators", Trends Biochem Sci, 31, pp.89~97 (2006)
- Jones PA, "Functions of DNA methylation : islands, start sites, gene bodies and beyond", Nat Rev Genet, 13, pp.484~492 (2012)
- Nagano T, "No-nonsense functions for long noncoding RNAs", Cell, 145, pp.178~181 (2011)
- Lin E, "Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy", Prog Neuropsychopharmacol Biol Psychiatry, 64, pp.334~340 (2016)
- Lutz PE, "DNA methylation and childhood maltreatment : from animal models to human studies", Neuroscience, 264, pp.142~156 (2014)
- Bakusic J, "Stress, burnout and depression : A systematic review on DNA methylation mechanisms", J Psychosom Res, 92, pp.34~44 (2017)
- Li M, "What do DNA methylation studies tell us about depression? A systematic review", Transl Psychiatry, 9, pp.68~ (2019)
- Lockwood LE, "The role of epigenetics in depression and suicide : A platform for gene–environment interactions", Psychiatry Res, 228, pp.235~242 (2015)
- Fuchikami M, "DNA methylation profiles of the brain-derived neurotrophic factor(BDNF)gene as a potent diagnostic biomarker in major depression", PLoS One, 6, pp.e23881~ (2011)
- Roth TL, "Lasting epigenetic influence of early-life adversity on the BDNF gene", Biol Psychiatry, 65, pp.760~769 (2009)
- Blaze J, "Long-term effects of early-life caregiving experiences on brain-derived neurotrophic factor histone acetylation in the adult rat mPFC", Stress, 18, pp.607~615 (2015)
- Doherty TS, "Global and gene-specific DNA methylation alterations in the adolescent amygdala and hippocampus in an animal model of caregiver maltreatment", Behav Brain Res, 298, pp.55~61 (2016)
- Hashimoto K, "Brain‐derived neurotrophic factor as a biomarker for mood disorders : an historical overview and future directions", Psychiatry Clin Neurosci, 64, pp.341~357 (2010)
- Champagne FA, "Maternal care associated with methylation of the estrogen receptor-α1b promoter and estrogen receptor-α expression in the medial preoptic area of female offspring", Endocrinology, 147, pp.2909~2915 (2006)
- Kinnally EL, "Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques", Genes Brain Behav, 9, pp.575~582 (2010)
- Murgatroyd C, "Dynamic DNA methylation programs persistent adverse effects of early-life stress", Nature Neuroscience, 12, pp.1559~1566 (2009)
- Uchida S, "Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events", Neuron, 69, pp.359~372 (2011)
- Weaver IC, "Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood", Proc Natl Acad Sci U S A, 103, pp.3480~3485 (2006)
- Zhang TY, "Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus", J Neurosci, 30, pp.13130~13137 (2010)
- Tyrka AR, "Methylation of the leukocyte glucocorticoid receptor gene promoter in adults : associations with early adversity and depressive, anxiety and substance-use disorders", Transl Psychiatry, 6, pp.e848~ (2016)
- Na KS, "Association between glucocorticoid receptor methylation and hippocampal subfields in major depressive disorder", PLoS One, 9, pp.e85425~ (2014)
- Webster M, "Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders", Mol Psychiatry, 7, pp.985~994 (2002)[DOI]
- McGowan PO, "Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse", Nature Neurosci, 12, pp.342~348 (2009)
- Weaver IC, "The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming : altering epigenetic marks by immediate-early genes", J Neurosci, 27, pp.1756~1768 (2007)
- Ernst C, "Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers", Arch Gen Psychiatry, 66, pp.22~32 (2009)
- Sabunciyan S, "Genome-wide DNA methylation scan in major depressive disorder", PLoS One, 7, pp.e34451~ (2012)
- Byrne E, "Monozygotic twins affected with major depressive disorder have greater variance in methylation than their unaffected co-twin", Transl Psychiatry, 3, pp.e269~ (2013)
- Numata S, "Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles : discovery and validation", Epigenetics, 10, pp.135~141 (2015)
- Uddin M, "Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample", Psychol Med, 41, pp.997~1007 (2011)
- Tseng PT, "Age-associated decrease in global DNA methylation in patients with major depression", Neuropsychiatr Dis Treat, 10, pp.2105~2114 (2014)
- Maffioletti E, "Peripheral whole blood microRNA alterations in major depression and bipolar disorder", J Affect Disord, 200, pp.250~258 (2016)
- Garbett KA, "Coordinated messenger RNA", microRNA changes in fibroblasts of patients with major depression, 2015, pp.77, 256~265
- Li YJ, "Alterations of serum levels of BDNF-related miRNAs in patients with depression", PLoS One, 8, pp.e63648~ (2013)
- Lopez JP, "miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment", Nat Med, 20, pp.764~768 (2014)
- Fan HM, "Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients", J Psychiatr Res, 59, pp.45~52 (2014)
- Mews P, "Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory", Nature, 546, pp.381~386 (2017)
- Pradeepa MM, "Histone H3 globular domain acetylation identifies a new class of enhancers", Nature Genet, 48, pp.681~686 (2016)
- Covington III HE, "Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition", Neurosci Lett, 493, pp.122~126 (2011)
- Hollis F, "Individual differences in the effect of social defeat on anhedonia and histone acetylation in the rat hippocampus", Horm Behav, 59, pp.331~337 (2011)
- Sun H, "Epigenetics of the depressed brain : role of histone acetylation and methylation", Neuropsychopharmacology, 38, pp.124~137 (2013)
- Covington HE, "Antidepressant actions of histone deacetylase inhibitors", J Neurosci, 29, pp.11451~11460 (2009)
- Hunter RG, "Regulation of hippocampal H3 histone methylation by acute and chronic stress", Proc Natl Acad Sci U S A, 106, pp.20912~20917 (2009)
- Deussing JM, "Neuroepigenomics in Aging and Disease", pp.169~183 (2017), Springer
- Fuchikami M, "The potential use of histone deacetylase inhibitors in the treatment of depression", Prog Neuropsychopharmacol Biol Psychiatry, 64, pp.320~324 (2016)
- Lin E, "Genome-wide association studies in pharmacogenomics of antidepressants", Pharmacogenomics, 16, pp.555~566 (2015)
- Lin E, "Machine Learning and Predictive Algorithms for Personalized Medicine: From Physiology to Treatment" (2016), Personalized Medicine Nova Science Publishers
- Lin E, "Gene–gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression", Rejuvenation Res, 12, pp.387~393 (2009)
- Lou XY, "A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence", Am J Hum Genet, 80, pp.1125~1137 (2007)
- Lin E, "Machine learning and systems genomics approaches for multi-omics data", Biomark Res, 5, pp.2~ (2017)
- Cirulli ET, "Uncovering the roles of rare variants in common disease through whole-genome sequencing", Nat Rev Genet, 11, pp.415~425 (2010)
- Bamshad MJ, "Exome sequencing as a tool for Mendelian disease gene discovery", Nat Rev Genet, 12, pp.745~755 (2011)
- Hodkinson BP, "Next-generation sequencing: a review of technologies and tools for wound microbiome research", Adv Wound Care (New Rochelle), 4, pp.50~58 (2015)
- Lin E, "A deep learning approach for predicting antidepressant response in major depression using clinical and genetic biomarkers", Front Psychiatry, 9, pp.290~ (2018)
- Lin E, "Combination of G72 genetic variation and G72 protein level to detect schizophrenia : machine learning approaches", Front Psychiatry, 9, pp.566~ (2018)
